Effect of single point mutations in a form of systemic amyloidosis.
about
Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis.Structure and energetic basis of overrepresented λ light chain in systemic light chain amyloidosis patients.Recent Developments and Applications of the MMPBSA Method.Convergent mechanisms favor fast amyloid formation in two lambda 6a Ig light chain mutants.
P2860
Effect of single point mutations in a form of systemic amyloidosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effect of single point mutations in a form of systemic amyloidosis.
@ast
Effect of single point mutations in a form of systemic amyloidosis.
@en
type
label
Effect of single point mutations in a form of systemic amyloidosis.
@ast
Effect of single point mutations in a form of systemic amyloidosis.
@en
prefLabel
Effect of single point mutations in a form of systemic amyloidosis.
@ast
Effect of single point mutations in a form of systemic amyloidosis.
@en
P2860
P356
P1433
P1476
Effect of single point mutations in a form of systemic amyloidosis
@en
P2093
Manikanthan Bhavaraju
P2860
P304
P356
10.1002/PRO.2730
P577
2015-07-14T00:00:00Z